Global Glycated Hemoglobin Testing Market 2015-2019
About Glycated Hemoglobin Testing
Glycated hemoglobin helps measure the concentration of glucose in the blood of an individual. HbA1c, a specific chemical form of glycated hemoglobin, is used to determine a person's average blood glucose level over a period. It is a standardized test recommended by doctors for the diagnosis of type 2 diabetes or to test the control level of the blood glucose. The testing can be done in a laboratory or at a POC center. Different types of technologies, such as chromatography, immunoassay, capillary electrophoresis, direct enzymatic assay, and micro-optical detection method, are used in HbA1c testing.
TechNavio's analysts forecast the Global Glycated Hemoglobin Testing market to grow at a CAGR of 10.22 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of Global Glycated Hemoglobin Testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of HbA1c products, including
TechNavio Announces the Publication of its Research Report – Global Glycated Hemoglobin Testing Market 2015-2019
TechNavio recognizes the following companies as the key players in the Global Glycated Hemoglobin Testing Market: Abbott Laboratories Inc., Alere Inc., Danaher Corp. and F. Hoffmann-La Roche Ltd.
Other Prominent Vendors in the market are: Arkray, Bayer, Bio-Rad Laboratories, Ceragem Medisys, Chek Diagnostics, Daiichi Biotech, DiaSys Diagnostic Systems, Diazyme Laboratories, EKF Diagnostics, Erba Mannheim, HUMAN Diagnostics, Lite-On Technology, Menarini, Mindray Medical, Randox Laboratories, Sebia, Siemens Healthcare, TaiDoc Technology, Tosoh Bioscience and Trinity Biotech.
Commenting on the report, an analyst from TechNavio’s team said: “One key trend upcoming in this market is the increased adoption of POC HbA1c testing. Rapid result outcomes and faster treatment decisions have increased the use of POC HbA1c testing for measuring blood glucose.”
According to the report, the growth of the Global Glycated Hemoglobin Testing market is predominantly driven by the growing incidence of diabetes in the world. An increase in the aging population, sedentary lifestyles, increasing obesity, and inappropriate dietary habits can lead to chronic diseases that foster the demand for HbA1c testing.
Further, the report states that the availability of substitute tests, such as test strips, glucose meters, lancets, and continuous blood glucose meters, poses a serious threat to the use of HbA1c testing.
Abbott Laboratories, Alere, Danaher, F. Hoffmann-La Roche , Arkray , Bayer , Bio-Rad Laboratories, Ceragem Medisys, Chek Diagnostics, Daiichi Biotech, DiaSys Diagnostic Systems, Diazyme Laboratories , EKF Diagnostics, Erba Mannheim, HumanDiagnostics, Lite-On Technology, Menarini , Mindray Medical, Randox Laboratories , Sebia, Siemens Healthcare, TaiDoc Technology, Tosoh Bioscience, Trinity Biotech